Incannex Healthcare Limit...

NASDAQ: IXHL · Real-Time Price · USD
0.39
-0.19 (-33.33%)
At close: Aug 01, 2025, 3:59 PM

Incannex Healthcare Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 29, 2023 Jun 30, 2023 Mar 30, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
98K 98K 86K 12K n/a n/a n/a n/a 270.08K 562.83K 562.83K 562.83K 562.85K 543.73K 997.53K 1.42M 1.3M 1.03M 575.92K
Cost of Revenue
n/a n/a n/a n/a 54.31K 54.31K 88.17K 88.17K 91.83K 154.68K 184.14K 247.12K 329.37K 408.58K 552.64K 682.23K 679.46K 540.37K 335.85K
Gross Profit
98K 98K 86K 12K n/a n/a n/a n/a 212.11K 567.69K 504.37K 441.4K 359.17K 135.14K 444.88K 736.68K 618.81K 486.86K 240.07K
Operating Income
-26M -28.42M -31.4M -30.03M -24.48M -20.72M -16.38M -32.4M -30.63M -29.61M -27.66M -8.43M -8.42M -8.23M -8M -7.67M -6.45M -4.66M -3.83M
Interest Income
100K 171K 163K 206K 253.13K 341.13K 376.13K 331.13K 247.86K 84.86K 30.52K 4.52K 662.05 662.05 1.38K 1.38K 1.38K 1.38K n/a
Pretax Income
-21.71M -23.78M -23.12M -18.43M -16.17M -13.71M -11.39M -31.2M -30.36M -30.4M -29.39M -10.75M -10.24M -9.5M -9.07M -8.54M -6.84M -4.64M -3.82M
Net Income
-21.74M -23.81M -23.15M -18.46M -16.17M -13.71M -11.39M -31.2M -30.36M -30.4M -29.39M -10.75M -10.24M -9.5M -9.07M -8.54M -7.34M -5.25M -4.52M
Selling & General & Admin
14.6M 16.47M 18.21M 17.06M 14.09M 11.96M 8.71M 8.18M 7.48M 7.21M 5.88M 4.87M 4.78M 4.58M 4.75M 4.85M 4.52M 3.52M 3.12M
Research & Development
11.4M 11.95M 13.17M 12.88M 10.13M 8.49M 7.4M 23.94M 23.37M 22.84M 22.16M 3.88M 3.87M 3.79M 3.7M 3.56M 2.55M 1.63M 945.66K
Other Expenses
103K 103K 103K 103K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
26.1M 28.52M 31.48M 30.05M 24.48M 20.72M 16.38M 32.4M 30.84M 30.05M 28.04M 8.75M 8.65M 8.37M 8.45M 8.41M 7.06M 5.14M 4.07M
Interest Expense
303K 171K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 643.60 643.60 643.60 643.60 n/a
Selling & Marketing Expenses
1.05M 1.05M 1.05M 1.05M 1.23M 1.23M 1.23M 1.24M 672.79K 1.38M 1.69M 1.98M 2.87M 3.72M 3.5M 3.28M 1.73M 218.9K 179.04K
Cost & Expenses
26.1M 28.52M 31.48M 30.05M 24.48M 20.72M 16.38M 32.4M 30.9M 30.17M 28.23M 8.99M 8.98M 8.78M 9M 9.09M 7.74M 5.69M 4.41M
Income Tax Expense
30K 30K 30K 30K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.13M -1.13M -1.13M
Shares Outstanding (Basic)
19.63M 17.62M 17.64M 17.04M 15.87M 15.87M 15.87M 15.63M 15.87M 15.4M 14.9M 308.63M 308.63M 286.95M 279.01M 262.97M 262.97M 225.53M 225.53M
Shares Outstanding (Diluted)
19.63M 17.62M 17.64M 17.04M 15.87M 15.87M 15.87M 15.63M 15.87M 15.4M 14.9M 308.62M 308.62M 286.95M 286.95M 262.95M 262.95M 225.51M 225.51M
EPS (Basic)
-1.2 -1.38 -1.38 -1.17 -1.06 -0.9 -0.76 -2.06 -1.8 -1.59 -1.41 -0.04 -0.04 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02
EPS (Diluted)
-1.2 -1.38 -1.38 -1.17 -1.06 -0.9 -0.76 -2.06 -1.8 -1.59 -1.41 -0.04 -0.04 -0.04 -0.04 -0.03 -0.03 -0.03 -0.02
EBITDA
-21.21M -23.39M -23.04M -18.44M -16.23M -13.96M -11.67M -13.77M -9.57M -5.84M -2.88M n/a n/a n/a n/a n/a -1.18M -1.83M -2.45M
EBIT
-22.21M -23.72M -23.25M -18.61M -16.17M -13.81M -11.52M -13.63M -11.92M -10.69M -9.41M -8.19M -8.28M -8.21M -7.97M -7.64M -6.37M -4.6M -3.77M
Depreciation & Amortization
247K 269K 155K 103K 95.31K 85.65K 91.15K 96.65K 2.35M 4.85M 6.52M 8.19M 8.28M 8.21M 7.97M 7.64M 5.26M 2.83M 1.38M